Skip to content
10-Q

Quarterly Report

TAMIR BIOTECHNOLOGY, INC.

0001308411-13-000123

← back to feed
Filed
May 7, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity Q1 2012 · Oct 31, 2011 −$6.26M
Stockholders Equity Q1 2012 · Jul 31, 2011 −$8.1M
Current Liabilities Q1 2012 · Oct 31, 2011 $5.87M
Current Liabilities Q1 2012 · Jul 31, 2011 $5.75M
Total Liabilities Q1 2012 · Oct 31, 2011 $6.54M
Total Liabilities Q1 2012 · Jul 31, 2011 $8.62M
Current Assets Q1 2012 · Oct 31, 2011 $193.6K
Current Assets Q1 2012 · Jul 31, 2011 $399.3K
Total Assets Q1 2012 · Oct 31, 2011 $281.21K
Total Assets Q1 2012 · Jul 31, 2011 $521.51K
Cash And Equivalents Q1 2012 · Jul 30, 2011 $354.2K
Cash And Equivalents Q1 2012 · Oct 31, 2010 $76.85K
Cash And Equivalents Q1 2012 · Jul 31, 2010 $321.25K
Shares Diluted Q1 2012 · Oct 31, 2010 47.32M sh
Capex Q1 2012 · Oct 31, 2010 $0
Operating Cash Flow Q1 2012 · Oct 31, 2010 −$242.75K
Eps Diluted Q1 2012 · Oct 31, 2010 −$0.19
Eps Basic Q1 2012 · Oct 31, 2010 −$0.19
Sga Expense Q1 2012 · Oct 31, 2010 $409.77K
Rd Expense Q1 2012 · Oct 31, 2010 $219.33K
Net Income Q1 2012 · Oct 31, 2010 −$8.86M
Operating Income Q1 2012 · Oct 31, 2010 −$629.1K
Revenue Q1 2012 · Oct 31, 2010 $0